Lozada, Elenita D.

HRN: 25-48-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/07/2026
04/14/2026
IV
2.25grams
Q8H
S/P ExLap Sigmoid Adenocarcinoma
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines